COVID-19 Stress Drives Anxiety-Reducing Supplement Sales Up 79% In US Since 2018
Executive Summary
Sales for anxiety/stress relief dietary supplements in 2020 grew 79% from 2018, eclipsing growth of 22% for general herbal supplements during the same comparison period. Stress-relief supplements including St. John’s wart, ashwagandha and cannabinoids continue to grow in popularity.
You may also be interested in...
Melatonin Dose Study, Steroid Warning Show Both Sides Of Coin For US Supplement Industry Image
Separate criticisms show opposite sides of the coin of public perception constantly flipping for businesses large and small making and marketing supplements available in US.
Symptoms Change But Savings OTC Drugs Deliver For US Health Care Spending Continue Growing
Substantially more consumers in 2022 report sleep issues, allergies and skin problems than in 2018 while using quit smoking aids has dropped, according to CHPA’s latest “Value of OTC Medicines” survey. Average annual household spending on OTCs is $645.
CDC Data On Children's Melatonin Emergencies Reported Without Context, Clarity, CRN Contends
CRN argues reporting melatonin overdoses are up 530% in past 10 years isn’t accurate representation of poison control report analysis by CDC.